Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 27 results.
User Information
Export Records
  1. 2.   Discovery and Optimization of 2H-1 lambda(2)-Pyridin-2-one Inhibitors of Mutant Isocitrate Dehydrogenase 1 for the Treatment of Cancer
  2. Rohde, Jason M.; Karavadhi, Surendra; Pragani, Rajan; Liu, Li; Fang, Yuhong; Zhang, Weihe; McIver, Andrew; Zheng, Hongchao; Liu, Qingyang; Davis, Mindy; Urban, Daniel J.; Lee, Tobie D.; Cheff, Dorian M.; Hollingshead,Melinda; Henderson, Mark J.; Martinez, Natalia J.; Brimacombe, Kyle R.; Yasgar, Adam; Zhao, Wei; Klumpp-Thomas, Carleen; Michael, Sam; Covey, Joseph; Moore,Bill; Stott, Gordon M.; Li, Zhuyin; Simeonov, Anton; Jadhav, Ajit; Frye, Stephen; Hall, Matthew D.; Shen, Min; Wang, Xiaodong; Patnaik, Samarjit; Boxer, Matthew B.
  3. Journal of Medicinal Chemistry. 2021, Apr 22; 64(8): 4913-4946.
  1. 3.   CENP-A overexpression promotes aneuploidy with karyotypic heterogeneity
  2. Shrestha, Roshan L.; Rossi, Austin; Wangsa, Darawalee; Hogan, Ann K.; Zaldana, Kimberly S.; Suva, Evelyn; Chung, Yang Jo; Sanders,Chelsea; Difilippantonio,Simone; Karpova, Tatiana S.; Karim,Baktiar; Foltz, Daniel R.; Fachinetti, Daniele; Aplan, Peter D.; Ried, Thomas; Basrai, Munira A.
  3. The Journal of Cell Biology. 2021, Feb 23; 220(4):
  1. 4.   Genomic mapping in outbred mice reveals overlap in genetic susceptibility for HZE ion- and gamma-ray-induced tumors
  2. Edmondson,Elijah; Gatti, D. M.; Ray, F. A.; Garcia, E. L.; Fallgren, C. M.; Kamstock, D. A.; Weil, M. M.
  3. SCIENCE ADVANCES. 2020, Apr; 6(16): eaax5940.
  1. 5.   Antibody-drug conjugates for cancer
  2. Chau, Cindy H.; Steeg,Pat; Figg, William D.
  3. Lancet (London, England). 2019, Aug 31; 394(10200): 793-804.
  1. 6.   IL-15/IL-15R alpha/CD80-expressing AML cell vaccines eradicate minimal residual disease in leukemic mice
  2. Shi, Yimin; Dincheva-Vogel, Lillie; Ayemoba, Charles E.; Fung, Jeffrey P.; Bergamaschi, Cristina; Pavlakis, George; Farzaneh, Farzin; Gaensler, Karin M. L.
  3. BLOOD ADVANCES. 2018, NOV 27; 2(22): 3177-3192.
  1. 7.   PAX3-FOXO1 Establishes Myogenic Super Enhancers and Confers BET Bromodomain Vulnerability
  2. Gryder, Berkley E.; Yohe, Marielle E.; Chou, Hsien-Chao; Zhang, Xiaohu; Marques, Joana; Wachtel, Marco; Schaefer, Beat; Sen, Nirmalya; Song, Young; Gualtieri, Alberto; Pomella, Silvia; Rota, Rossella; Cleveland, Abigail; Wen, Xinyu; Sindiri, Sivasish; Wei, Jun S.; Barr, Frederic G.; Das, Sudipto; Andresson, Thorkell; Guha, Rajarshi; Lal-Nag, Madhu; Ferrer, Marc; Shern, Jack F.; Zhao, Keji; Thomas, Craig J.; Khan, Javed
  3. Cancer Discovery. 2017, Aug; 7(8): 884-899.
  1. 8.   Hematopoiesis and leukemogenesis in mice expressing oncogenic Nras(G12D) from the endogenous locus
  2. Li, Q.; Haigis, K. M.; McDaniel, A.; Harding-Theobald, E.; Kogan, S. C.; Akagi, K.; Wong, J. C. Y.; Braun, B. S.; Wolff, L.; Jacks, T.; Shannon, K.
  3. Blood. 2011, Feb; 117(6): 2022-2032.
  1. 9.   Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation
  2. Yap, D. B.; Chu, J.; Berg, T.; Schapira, M.; Cheng, S. W. G.; Moradian, A.; Morin, R. D.; Mungall, A. J.; Meissner, B.; Boyle, M.; Marquez, V. E.; Marra, M. A.; Gascoyne, R. D.; Humphries, R. K.; Arrowsmith, C. H.; Morin, G. B.; Aparicio, S.
  3. Blood. 2011, Feb; 117(8): 2451-2459.
  1. 10.   Genetically modified dendritic cells in cancer immunotherapy: a better tomorrow?
  2. Shurin, M. R.; Gregory, M.; Morris, J. C.; Malyguine, A. M.
  3. Expert Opinion on Biological Therapy. 2010, Nov; 10(11): 1539-1553.
  1. 11.   Identification of Vitronectin as an Extrinsic Inducer of Cancer Stem Cell Differentiation and Tumor Formation
  2. Hurt, E. M.; Chan, K.; Serrat, M. A. D.; Thomas, S. B.; Veenstra, T. D.; Farrar, W. L.
  3. Stem Cells. 2010, Mar 31; 28(3): 390-398.
  1. 12.   Recent Development of Cyclic Amide (Pyridone/Lactam) Moiety Containing Heterocycles as Protein Kinase Inhibitors
  2. Wei, L. Y.; Malhotra, S. V.
  3. Current Medicinal Chemistry. 2010, Jan; 17(3): 234-253.
  1. 13.   Glioblastoma stem cells produce vascular endothelial growth factor by activation of a G-protein coupled formylpeptide receptor FPR
  2. Yao, X. H.; Ping, Y. F.; Chen, J. H.; Xu, C. P.; Chen, D. L.; Zhang, R.; Wang, J. M.; Bian, X. W.
  3. Journal of Pathology. 2008 215(4): 369-376.
  1. 14.   Isolation and characterization of stem cell-like precursor cells from primary human anaplastic oligoastrocytoma
  2. Yi, L.; Zhou, Z. H.; Ping, Y. F.; Chen, J. H.; Yao, X. H.; Feng, H.; Lu, J. Y.; Wang, J. M.; Bian, X. W.
  3. Modern Pathology. 2007, Oct; 20(10): 1061-1068.
  1. 15.   Cancer stem cells - Redefining the paradigm of cancer treatment strategies
  2. Dean, M.
  3. Molecular Interventions. 2006, Jun; 6(3): 140-148.
  1. 16.   Cooperating cancer-gene identification through oncogenic-retrovirus-induced insertional mutagenesis
  2. Du, Y.; Spence, S. E.; Jenkins, N. A.; Copeland, N. G.
  3. Blood. 2005, OCT 1; 106(7): 2498-2505.
  1. 17.   Tumour stem cells and drug resistance
  2. Dean, M.; Fojo, T.; Bates, S.
  3. Nature Reviews Cancer. 2005 5(4): 275-284.
  1. 18.   Role of protein-protein interactions in the antiapoptotic function of EWS-Fli-1
  2. Ramakrishnan, R.; Fujimura, Y.; Zou, J. P.; Liu, F.; Lee, L.; Rao, V. N.; Reddy, E. S. P.
  3. Oncogene. 2004, SEP 16; 23(42): 7087-7094.
  1. 19.   Small molecule toxins targeting tumor receptors
  2. Dyba, M.; Tarasova, N. I.; Michejda, C. J.
  3. Current Pharmaceutical Design. 2004 10(19): 2311-2334.
  1. 20.   Hematopoietic, angiogenic and eye defects in Meis1 mutant animals
  2. Hisa, T.; Spence, S. E.; Rachel, R. A.; Fujita, M.; Nakamura, T.; Ward, J. M.; Devor-Henneman, D. E.; Saiki, Y.; Kutsuna, H.; Tessarollo, L.; Jenkins, N. A.; Copeland, N. G.
  3. Embo Journal. 2004 23(2): 450-459.
  1. 21.   Structural basis for DNA recognition by the basic region leucine zipper transcription factor CCAAT/enhancer-binding protein alpha
  2. Miller, M.; Shuman, J. D.; Sebastian, T.; Dauter, Z.; Johnson, P. F.
  3. Journal of Biological Chemistry. 2003 278(17): 15178-15184.
  1. 22.   EWS-ATF-1 chimeric protein in soft tissue clear cell sarcoma associates with CREB-binding protein and interferes with p53- mediated trans-activation function
  2. Fujimura, Y.; Siddique, H.; Lee, L.; Rao, V. N.; Reddy, E. S. P.
  3. Oncogene. 2001 20(46): 6653-6659.
  1. 23.   BP1, a new homeobox gene, is frequently expressed in acute leukemias
  2. Haga, S. B.; Fu, S.; Karp, J. E.; Ross, D. D.; Williams, D. M.; Hankins, W. D.; Behm, F.; Ruscetti, F. W.; Chang, M.; Smith, B. D.; Becton, D.; Raimondi, S. C.; Berg, P. E.
  3. Leukemia. 2000 14(11): 1867-1875.
  1. 24.   Transcription-coupled translation control of AML1/RUNX1 is mediated by cap- and internal ribosome entry site-dependent mechanisms
  2. Pozner, A.; Goldenberg, D.; Negreanu, V.; Le, S. Y.; Elroy-Stein, O.; Levanon, D.; Groner, Y.
  3. Molecular and Cellular Biology. 2000 20(7): 2297-2307.
  1. 25.   The ras oncogene-mediated sensitization of human cells to topoisomerase II inhibitor-induced apoptosis
  2. Koo, H. M.; Gray-Goodrich, M.; Kohlhagen, G.; McWilliams, M. J.; Jeffers, M.; Vaigro-Wolff, A.; Alvord, W. G.; Monks, A.; Paull, K. D.; Pommier, Y.; Vande Woude, G. F.
  3. Journal of the National Cancer Institute. 1999 91(3): 236-244.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel